Dr. Sitaram Emani, MD
Claim this profileBoston Children's Hospital
Studies Hypoplastic Left Heart Syndrome
Studies Single Ventricle Heart
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Sitaram Emani, MD is currently running
Lomecel-B Injection
for Hypoplastic Left Heart Syndrome
The purpose of this study is to test whether Lomecel-B™ works in treating patients with hypoplastic left heart syndrome (HLHS) and to gather additional information about the safety of Lomecel-B. Lomecel-B contains human mesenchymal stem cells (MSCs) as the active ingredient. MSCs are special cells in the body that are able to change into other types of cells, such as heart, blood, and muscle cells. MSCs are found in various tissues of the body, such as the bone marrow, which is the spongy tissue inside of your bones. Lomecel-B uses MSCs from bone marrow of unrelated young healthy donors. These are called "allogeneic", and do not require donor matching to the patient.
Recruiting1 award Phase 21 criteria
Mitochondria Transplantation
for Heart Ischemia
The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.
Recruiting1 award N/A
More about Sitaram Emani, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sitaram Emani, MD has experience with
- MPC
- Autologous Mitochondria Transplantation
- Lomecel-B
Breakdown of trials Sitaram Emani, MD has run
Hypoplastic Left Heart Syndrome
Single Ventricle Heart
Atrial Septal Defect
Extracorporeal Membrane Oxygenation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sitaram Emani, MD specialize in?
Sitaram Emani, MD focuses on Hypoplastic Left Heart Syndrome and Single Ventricle Heart. In particular, much of their work with Hypoplastic Left Heart Syndrome has involved Stage II patients, or patients who are undergoing treatment.
Is Sitaram Emani, MD currently recruiting for clinical trials?
Yes, Sitaram Emani, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sitaram Emani, MD has studied deeply?
Yes, Sitaram Emani, MD has studied treatments such as MPC, Autologous Mitochondria Transplantation, Lomecel-B.
What is the best way to schedule an appointment with Sitaram Emani, MD?
Apply for one of the trials that Sitaram Emani, MD is conducting.
What is the office address of Sitaram Emani, MD?
The office of Sitaram Emani, MD is located at: Boston Children's Hospital, Boston, Massachusetts 02115 United States. This is the address for their practice at the Boston Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.